Table 2. Seroprevalence of toxoplasmosis from reports of neighboring countries.
Author | Country | Population | Number | Method | Prevalence % (95% CI) | P-value | Reference |
Belkacemi M and Heddi B (2022) | Algeria | Blood donors | 103 | ELISA | 44.7 (35.1-54.3) | Current Study | |
Messerer L et al. (2014) | Algeria | Pregnant women | 1028 | EIA | 47.80 (44.80-51.00) | NS | [5] |
Lachkhem A et al. (2020) | Tunisia | Blood donors | 800 | ELISA-IFA | 44.40 (40.93-47.82) | NS | [6] |
Laboudi M (2014) | Morocco | Pregnant women | 1169 | ELISA | 47.00 (46.97-47.03) | NS | [7] |
Mousa DA et al. (2011) | Libya | Pregnant women | 143 | ELISA | 44.80 (44.72-44.88) | NS | [8] |
Elsheikha HM et al. (2004) | Egypt | Blood donors | 260 | ELISA | 59.60 (95.54-59.66) | NS | [9] |
Siransy L et al. (2016) | Ivory Coast | Blood donors | 106 | ELISA | 67.92 (67.83-68.01) | = 0.0210 | [10] |
Abamecha F and Awel H (2016) | Ethiopia | Pregnant women | 232 | ELISA | 85.30 (85.35-85.25) | <0.0001 | [11] |
Doudou Y et al. (2014) | Congo | Pregnant women | 781 | ELISA | 80.30 (77.50-83.10) | <0.0001 | [12] |